Aurinia Pharmaceuticals Inc. 10-Q filing
Filed 2025-07-31 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001600620-25-000092
- Form type
- 10-Q
- CIK
- 0001600620
- Primary document
- https://www.sec.gov/Archives/edgar/data/1600620/000160062025000092/auph-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aurinia Pharmaceuticals Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $132.5M | - | - |
| Cost Of Revenue | $15.7M | - | - |
| Operating Income | $41.9M | - | - |
| Net Income | $44.9M | - | - |
| Eps Basic | 0.33 | - | - |
| Eps Diluted | 0.32 | - | - |
| Cash And Equivalents | $52.9M | - | - |
| Total Assets | $502.6M | - | - |
| Total Liabilities | $167.3M | - | - |
| Shareholders Equity | $335.3M | - | - |
| Operating Cash Flow | $45.5M | - | - |